SUSQUEHANNA FUNDAMENTAL INVESTMENTS, LLC - HAEMONETICS CORP ownership

HAEMONETICS CORP's ticker is HAE and the CUSIP is 405024100. A total of 244 filers reported holding HAEMONETICS CORP in Q2 2022. The put-call ratio across all filers is 1.27 and the average weighting 0.1%.

Quarter-by-quarter ownership
SUSQUEHANNA FUNDAMENTAL INVESTMENTS, LLC ownership history of HAEMONETICS CORP
ValueSharesWeighting
Q2 2023$2,371,149
-54.4%
27,850
-55.7%
0.09%
-28.1%
Q1 2023$5,203,486
-10.6%
62,882
-15.0%
0.12%
+21.0%
Q4 2022$5,817,976
+6.2%
73,9730.0%0.10%
+7.5%
Q3 2022$5,476,000
+24.1%
73,973
+6.0%
0.09%
+8.1%
Q1 2022$4,412,000
+11.9%
69,787
-6.1%
0.09%
-16.5%
Q4 2021$3,943,000
+22.9%
74,347
+63.6%
0.10%
+74.6%
Q3 2021$3,207,000
+427.5%
45,437
+397.7%
0.06%
+436.4%
Q2 2021$608,000
-62.8%
9,129
-38.0%
0.01%
-60.7%
Q1 2021$1,635,00014,7270.03%
Other shareholders
HAEMONETICS CORP shareholders Q2 2022
NameSharesValueWeighting ↓
LGT CAPITAL PARTNERS LTD. 1,216,059$64,500,0001.72%
HEARTLAND ADVISORS INC 406,192$21,544,0001.26%
KINGDON CAPITAL MANAGEMENT, L.L.C. 200,000$10,608,0001.22%
Aurora Investment Counsel 32,149$1,705,0001.01%
Endurant Capital Management LP 73,914$3,920,0000.95%
KINGDON CAPITAL MANAGEMENT, L.L.C. 135,000$7,160,0000.82%
ARMISTICE CAPITAL, LLC 872,000$46,251,0000.76%
Summit Creek Advisors LLC 131,357$6,967,0000.70%
Dean Capital Management 15,309$812,0000.70%
Keene & Associates, Inc. 11,720$622,0000.54%
View complete list of HAEMONETICS CORP shareholders